CTOs on the Move

Mortara Instrument

www.mortara.com

 
Founded in 1982 by David W. Mortara, PhD, Mortara Instrument was born with a guiding philosophy: design to a need, keep it simple, and make it economically accessible. Building on this philosophy, Mortara Instrument has created a complete line of
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.mortara.com
  • 7865 N 86th St
    Milwaukee, WI USA 53224
  • Phone: 414.354.1600

Executives

Name Title Contact Details

Similar Companies

Nuvo Group

NUVO GROUP- Developing the Future of Pregnancy Nuvo Group is committed to transforming pregnancy care for a new generation. We are focused on developing wearable, sensor-based technologies that utilize big data analytics to drastically improve pregnancy healthcare on a global scale. PregSense™ Meet the next generation solution to prenatal monitoring. PregSense™ is the first and only all-in-one pregnancy monitoring designed for remote monitoring and continuous data collection. The wearable, multimodal and wireless platform simultaneously captures multiple data sets from both the mother and the fetus, providing more insights to doctors and a better experience for expecting mothers. Our Team Nuvo Group is made up of a diverse, global group of dedicated engineers, scientists and proud parents. Our experience in product design and compliance coupled with our passion for forging new advancements in technologies, big data, apps and cloud-based analytics makes us the ideal partner to drastically improve prenatal care on a global level.

Hantel Technologies

Hantel Technologies is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sequana Medical

Sequana Medical is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amico Corporation

Amico Corporation is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pulse Biosciences

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.